We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
+5.23%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$57.1B
AUM Growth
+$7.09B
Cap. Flow
+$5.14B
Cap. Flow %
9%
Top 10 Hldgs %
8.79%
Holding
2,416
New
255
Increased
1,207
Reduced
743
Closed
179

Sector Composition

Rank Sector Weight
1 Financials 15.15%
2 Healthcare 14.49%
3 Technology 14.13%
4 Consumer Discretionary 13.89%
5 Industrials 12.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
26
General Dynamics
GD
$105B
$327M 0.57%
2,378,751
-49,777
-2% -$7.11M
HD icon
27
Home Depot
HD
$349B
$322M 0.56%
2,434,302
-656,789
-21% -$83.6M
LYB icon
28
LyondellBasell Industries
LYB
$19.8B
$320M 0.56%
3,683,371
+1,404,452
+62% +$129M
TSM icon
29
TSMC
TSM
$2.17T
$311M 0.54%
13,659,984
+2,404,465
+21% +$54.1M
EA icon
30
Electronic Arts
EA
$285M 0.5%
4,149,190
+23,373
+0.6% +$1.64M
UTHR icon
31
United Therapeutics
UTHR
$22.6B
$280M 0.49%
1,788,772
+485,617
+37% +$70.7M
DAL icon
32
Delta Air Lines
DAL
$60.5B
$279M 0.49%
5,511,429
-524,433
-9% -$25.9M
MCK icon
33
McKesson
MCK
$102B
$278M 0.49%
1,409,723
+416,625
+42% +$78.7M
PG icon
34
Procter & Gamble
PG
$342B
$274M 0.48%
3,449,140
-1,318,553
-28% -$101M
CCL icon
35
Carnival Corporation Ltd
CCL
$39.4B
$266M 0.46%
4,873,756
+720,571
+17% +$37.3M
JNJ icon
36
Johnson & Johnson
JNJ
$619B
$263M 0.46%
2,560,922
-1,001,576
-28% -$101M
CVS icon
37
CVS Health
CVS
$123B
$256M 0.45%
2,614,112
-1,416,654
-35% -$139M
KEY icon
38
KeyCorp
KEY
$24.3B
$249M 0.44%
18,910,878
-894,059
-5% -$11.7M
BIIB icon
39
Biogen
BIIB
$30.5B
$249M 0.44%
813,093
-167,066
-17% -$48M
KMB icon
40
Kimberly-Clark
KMB
$36.1B
$249M 0.44%
1,952,520
-195,772
-9% -$23.5M
EW icon
41
Edwards Lifesciences
EW
$51.5B
$246M 0.43%
9,342,720
-3,297,678
-26% -$85.6M
LUV icon
42
Southwest Airlines
LUV
$23B
$243M 0.42%
5,634,408
-2,961,961
-34% -$131M
MRK icon
43
Merck
MRK
$317B
$243M 0.42%
4,812,985
-2,412,296
-33% -$122M
KR icon
44
Kroger
KR
$35.1B
$235M 0.41%
5,622,094
-1,092,855
-16% -$42.4M
INFY icon
45
Infosys
INFY
$50.1B
$232M 0.41%
27,655,084
+1,203,510
+5% +$10.4M
C icon
46
Citigroup
C
$224B
$230M 0.4%
4,453,408
-568,040
-11% -$30.1M
ZTS icon
47
Zoetis
ZTS
$32.4B
$229M 0.4%
4,785,475
-289,133
-6% -$13.1M
YUM icon
48
Yum! Brands
YUM
$41.6B
$229M 0.4%
4,361,261
+3,000,974
+221% +$157M
AIZ icon
49
Assurant
AIZ
$14.7B
$228M 0.4%
2,832,461
+298,649
+12% +$24.6M
JPM icon
50
JPMorgan Chase
JPM
$947B
$227M 0.4%
3,437,071
-475,899
-12% -$31M

Similar funds

AQR Capital Management's Q4 2015 Portfolio in Review

As of Q4 2015, AQR Capital Management held 2,416 positions worth $57.1B, up 14% from $50B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

AQR Capital Management deployed $5.14B of net new capital in Q4 2015, opening 255 new positions and adding to 1,207 existing holdings. Its largest new stake was Alphabet (Google) Class A: 10,884,520 shares worth $423M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $233M trimmed.

  • AQR Capital Management's largest Q4 2015 buy was Alphabet (Google) Class A: 10,884,520 shares worth $423M.
  • AQR Capital Management added most to Citizens Financial Group in Q4 2015, an estimated $190M increase.
  • AQR Capital Management's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $233M.
  • AQR Capital Management fully exited HUBBELL INC CL-B in Q4 2015, selling an estimated $11.5M.
  • AQR Capital Management's ten largest holdings make up 8.8% of its $57.1B portfolio in Q4 2015.
  • AQR Capital Management opened 255 new positions and closed 179 in Q4 2015.
  • AQR Capital Management's portfolio value rose 14% quarter-over-quarter to $57.1B.

Based on AQR Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.